Surprisingly, miR-338–5p and miR-421, which we previously validated as tumor suppressor miRNAs in prostate cancer (53), were also present among the predicted miRNAs that interacted with MALAT1 (Fig. 5A). Here, MALAT1 is linked to neoplasm.